62 results

... of 95 to 109 mm Hg, after a placebo washout period, to receive placebo or one of six ... maintenance phase, each patient entered a four-week placebo washout phase. Patients who had been randomly assigned to ...

... failed an active treatment and withdrew during the placebo washout phase, the com- bined response rate was 76. ...

... of ivacaftor, 14 days post- 12.5) or placebo, every 12 washout period Exclusion BMI 75mg: 10.0 (4.5 ... 4.4 (0 to without appropriate 18.3) washout Placebo: 7.3 (5.2 to 8.2) Difference ...

... four- weeks, and 150mg Mean, percentage value) week washout placebo every 12 hours points (SD) −2.22 (p= ... 4) for 4 weeks OR (2) 150mg of placebo every 12 hours for 4 weeks, washout for 4 weeks, and 150mg ivacaftor every 12 ...

... 2 week baseline–4 weeks of drug or placebo–1 week washout–4 weeks of Limitations to generalizability: This sample ...

... 17.8) followed by 4 (combined w/ prior placebo disorder/mood disorder, n (%) weeks washout group) 2) 61 (64.9)/33 (35.1) ... 7 (9.6) 2) 2.4 VE and Washout periods 2) 47.2 (11.2) 3) 2.2 2) VBZ 40 mg/day, n=97 3) 47.6 (13.6) (combined w/ prior placebo group) Male, n (%) 1) 34 (68.0) 3) ...

... 0022 in comparison with beverage with 48-hr washout postmenopausal, or hydrocodone IR between. Subjects had to using a medically distinguish between placebo and acceptable Drug liking VAS, Emax Mean hydrocodone ...

... doses of brodalumab URIs (≥5% in any or placebo DLQI: HADS-A (treatment group): Exclusion: A washout difference, after 1) 8.2, 2) 8.1, 3) 6.4 period was required NR imputation): for patients receiving PsA (%): 1) -1.3, 2) -1.5 ... supplementary p<0.001 appendix) Previous biologics (%): HADS- ...

... Pulse rate was recorded at each clinic visit. Placebo Period The pretreatment BP and the compliance of the patient were determined during the prerandomization period. Following a drug washout period of 4 weeks, if patients were on ...

... but partially recovered to LVEF 50% during the washout period. Three patients on mavacamten and three patients on placebo temporarily discontinued due to changes in QT interval. ...